Affiliation:
1. University of Cincinnati College of Medicine; Cincinnati OH
2. University of California San Francisco; San Francisco CA
3. Johns Hopkins University; Baltimore MD
Funder
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products
Merck & Co., Inc.
ViiV Healthcare
Intercept Pharmaceuticals, Inc.
Tobira Therapeutics, Inc
National Institutes of Health
National Institute of Allergy and Infectious Diseases
National Institute on Drug Abuse
Reference109 articles.
1. HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter AIDS Cohort Study (MACS);Thio;Lancet,2002
2. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study;Kirk;Ann Intern Med,2013
3. End-stage liver disease in persons with hemophilia and transfusion-associated infections;Goedert;Blood,2002
4. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study;Lo Re;Ann Intern Med,2014
5. HIV increases HCV replication in a TGF-beta1-dependent manner;Lin;Gastroenterology,2008
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献